Free Newsletter

FierceVaccines is a weekly update on the vaccine industry, with a special focus on the innovations revolutionizing the development and production of vaccines. Join thousands of lab research professionals who get FierceVaccines via weekly email. Sign up today!

About | View Sample | Privacy

Hottest Products

Compare Top Solutions in:

Evaluate more than 400,000 products >>

Featured Jobs

Analyst, Procurement Operations Job
Celgene Corporation - Basking Ridge, NJ, US
Supervisor, Manufacturing (Compounder) Job
Celgene Corporation - Phoenix, AZ, US
Manager, Regulatory CMC Job
Celgene Corporation - Basking Ridge, NJ, US
Director, Clinical Research Physician - Early Development II Job
Celgene Corporation - Warren Township, NJ, US
Principal Scientist
Watson Pharmaceuticals - Fort Lauderdale, FL

More Jobs >>

Events

BioMalaysia 2011 & The 6th Pacific Rim Summit
November 21-23 — Nov Kuala Lumpur Convention Centre,
Electronic Submissions 2011 - 10th Anniversary Conference: Moving into the Next Generation of Electronic Submission Standards
November 16-17, 2011 — San Diego, CA
Health Market Science Webinar: 3 Steps to New Physician Opportunities
Nov. 17
How to Build a Biotech Company 101, A Comprehensive One Day Program for Entrepreneurs
January 10, 2012 — San Francisco, CA

More Events >>

Related Tags >> glioblastoma therapeutic vaccines ImmunoCellular Therapeutics

ICT-107 News

Most Popular ICT-107 Story

ICT-107 - 10 promising therapeutic vaccines

October 27, 2011 — 8:07am ET

Vaccine: ICT-107Company: ImmunoCellular TherapeuticsTarget: Glioblastoma Like a growing number of therapeutic vaccines in development, ICT-107 takes advantage of the role that dendritic cells play in Read more...

Latest Headlines

ICT-107 - 10 promising therapeutic vaccines
October 27, 2011

Paid Research Reports

Trends in mHealth and Telemedicine
The Global Aesthetic Dermatology Market Outlook
Future Directions in Regenerative Medicine
Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline

More Research Reports >>

THE FIERCEMARKETS NETWORK